ArticleChina CDC weekly2025
HPV Genotypes and Associated Disease Prevalence in Males with Confirmed HPV Exposure - Shenzhen City, Guangdong Province, China, 2018-2022.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Human papillomavirus (HPV) is a globally prevalent sexually transmitted infection, with multiple genotypes strongly associated with cancers and other diseases. While extensive epidemiological data exist for HPV in females, studies on HPV genotype distribution in males, particularly those with confirmed HPV exposure, remain limited. What is added by this report?: This study provides a comprehensive analysis of HPV genotype distribution and its association with clinical outcomes in males with confirmed HPV exposure. The results demonstrate that low-risk HPV genotypes predominate in this population, with certain diseases showing unique HPV genotype associations. Additionally, older males exhibited a greater tendency toward multiple genotype co-infections. What are the implications for public health practice?: This study underscores the importance of including males in HPV vaccination programs. Expanding vaccination coverage to males, combined with early screening and targeted public health education, can effectively reduce HPV transmission between sexes and decrease the overall burden of HPV-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.